Inflammatory infiltrates in parathyroid tumors

Context Inflammatory infiltrates are sometimes present in solid tumors and may be coupled to clinical behavior or etiology. Infectious viruses contribute to tumorigenesis in a significant fraction of human neoplasias. Objective Characterize inflammatory infiltrates and possible viral transcription in primary hyperparathyroidism. Design From the period 2007 to 2016, a total of 55 parathyroid tumors (51 adenomas and 4 hyperplasias) with prominent inflammatory infiltrates were identified from more than 2000 parathyroid tumors in the pathology archives, and investigated by immunohistochemistry for CD4, CD8, CD20 and CD45 and scored as +0, +1 or +2. Clinicopathological data were compared to 142 parathyroid adenomas without histological evidence of inflammation. Transcriptome sequencing was performed for 13 parathyroid tumors (four inflammatory, 9 non-inflammatory) to identify potential viral transcripts. Results Tumors had prominent germinal center-like nodular (+2) lymphocytic infiltrates consisting of T and B lymphocytes (31%) and/or diffuse (+1–2) infiltrates of predominantly CD8+ T lymphocytes (84%). In the majority of cases with adjacent normal parathyroid tissue, the normal rim was unaffected by the inflammatory infiltrates (96%). Presence of inflammatory infiltrates was associated with higher levels of serum-PTH (P = 0.007) and oxyphilic differentiation (P = 0.002). Co-existent autoimmune disease was observed in 27% of patients with inflammatory infiltrates, which in turn was associated with oxyphilic differentiation (P = 0.041). Additionally, prescription of anti-inflammatory drugs was associated with lower serum ionized calcium (P = 0.037). Conclusions No evidence of virus-like sequences in the parathyroid tumors could be found by transcriptome sequencing, suggesting that other factors may contribute to attract the immune system to the parathyroid tumor tissue.

[1]  C. Larsson,et al.  Diffuse PTH expression in parathyroid tumors argues against important functional tumor subclones , 2016, European journal of endocrinology.

[2]  Mechthild Krause,et al.  CD8+ tumour‐infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK‐ROG) , 2016, International journal of cancer.

[3]  J. Hartman,et al.  Tumour nuclear oestrogen receptor beta 1 correlates inversely with parathyroid tumour weight , 2015, Endocrine connections.

[4]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[5]  A. Arnold,et al.  Genetic and epigenetic changes in sporadic endocrine tumors: Parathyroid tumors , 2014, Molecular and Cellular Endocrinology.

[6]  J. Olson,et al.  Functional and genetic studies of isolated cells from parathyroid tumors reveal the complex pathogenesis of parathyroid neoplasia , 2014, Proceedings of the National Academy of Sciences.

[7]  T. Samuelsson,et al.  The landscape of viral expression and host gene fusion and adaptation in human cancer , 2013, Nature Communications.

[8]  H. Schreiber,et al.  Innate and adaptive immune cells in the tumor microenvironment , 2013, Nature Immunology.

[9]  M. Spampatti,et al.  Chronic autoimmune atrophic gastritis associated with primary hyperparathyroidism: a transversal prospective study. , 2013, European journal of endocrinology.

[10]  S. Janković,et al.  Is there a link between Hashimoto's thyroiditis and primary hyperparathyroidism? A study of serum parathormone and anti-TPO antibodies in 2267 patients. , 2013, Hellenic journal of nuclear medicine.

[11]  Mamoon Rashid,et al.  READSCAN: a fast and scalable pathogen discovery program with accurate genome relative abundance estimation , 2012, Bioinform..

[12]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[13]  Inga-Lena Nilsson,et al.  Evidence of a functional estrogen receptor in parathyroid adenomas. , 2012, The Journal of clinical endocrinology and metabolism.

[14]  M. Charitou,et al.  Hypercalcemia in a patient with autoimmune polyglandular syndrome , 2012, Clinics and practice.

[15]  C. Larsson,et al.  Genetic characterization of large parathyroid adenomas , 2012, Endocrine-related cancer.

[16]  S. Diaz-Cano,et al.  Inflammatory diseases of the parathyroid gland , 2011, Histopathology.

[17]  J. Lundeberg,et al.  Scalable Transcriptome Preparation for Massive Parallel Sequencing , 2011, PloS one.

[18]  C. Boitard,et al.  Hyperparathyroidism in a patient with autoimmune polyglandular syndrome. , 2008, Internal medicine.

[19]  G. Swift,et al.  Coeliac disease and primary hyperparathyroidism: an association? , 2006, Postgraduate Medical Journal.

[20]  M. Cho,et al.  Relationship between Epstein-Barr Virus-Encoded RNA Expression, Apoptosis and Lymphocytic Infiltration in Gastric Carcinoma with Lymphoid-Rich Stroma , 2004, Medical Principles and Practice.

[21]  T. Sasagawa,et al.  Expression of Epstein-Barr virus in thyroid carcinoma correlates with tumor progression. , 2003, Human pathology.

[22]  V. Pankratz,et al.  Lymphocyte-Rich Gastric Cancer: Associations with Epstein-Barr Virus, Microsatellite Instability, Histology, and Survival , 2003, Modern Pathology.

[23]  G. Parham,et al.  Induction of Human Papillomavirus-Specific CD4+ and CD8+ Lymphocytes by E7-Pulsed Autologous Dendritic Cells in Patients with Human Papillomavirus Type 16- and 18-Positive Cervical Cancer , 1999, Journal of Virology.

[24]  J. Rastad,et al.  Major histocompatibility complex class II expression and parathyroid autoantibodies in primary hyperparathyroidism. , 1998, Surgery.

[25]  P. Bruggen,et al.  Human tumor antigens recognized by T lymphocytes , 1996, The Journal of experimental medicine.

[26]  R. Brown,et al.  The relationship between adenoma weight and intact (1-84) parathyroid hormone level in primary hyperparathyroidism. , 1992, American journal of surgery.